| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/13/2000 | WO1999053047A3 Porcine adenovirus type 3 genome |
| 01/13/2000 | WO1999051259A3 Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines |
| 01/13/2000 | WO1999037774A3 Differentiation-associated sequences and methods of use therefor |
| 01/13/2000 | CA2402839A1 Galectin 11 |
| 01/13/2000 | CA2337048A1 Use of an amphipathic compound for providing an adjuvant to a subunit vaccine |
| 01/13/2000 | CA2336739A1 Trifunctional reagent for conjugation to a biomolecule |
| 01/13/2000 | CA2336406A1 Galectin 11 |
| 01/13/2000 | CA2336320A1 Haemophilus parasuis vaccine and diagnostic |
| 01/13/2000 | CA2332345A1 Flt3-l mutants and methods of use |
| 01/13/2000 | CA2331829A1 Kv6.2, a voltage-gated potassium channel subunit |
| 01/12/2000 | EP0970966A1 Fungal antigens and process for producing the same |
| 01/12/2000 | EP0970243A1 Diagnosis and treatment of glaucoma |
| 01/12/2000 | EP0970232A2 Non-immunogenic prodrugs and selectable markers for use in gene therapy |
| 01/12/2000 | EP0970227A1 Recombinant antibodies and immunoconjugates targeted to cd-22 bearing cells and tumors |
| 01/12/2000 | EP0970220A1 Method for producing non-infectious recombinant picornavirus particles |
| 01/12/2000 | EP0970219A1 A porin gene from campylobacter jejuni, related products and uses thereof |
| 01/12/2000 | EP0970217A2 Anti-alpha-v beta-3 recombinant humanized antibodies, nucleic acids encoding same and methods of use |
| 01/12/2000 | EP0970213A2 Death domain containing receptor 5 |
| 01/12/2000 | EP0970211A1 Variants of ciliary neurotrophic factor with enhanced receptor selectivity and method for their selection |
| 01/12/2000 | EP0970206A1 Lage-1 tumor associated nucleic acids |
| 01/12/2000 | EP0970203A2 Agents for pre-symptomatic detection and therapeutic targeting of alzheimer's disease and down syndrome in humans |
| 01/12/2000 | EP0970190A1 Isolated viable parasite intestinal cells |
| 01/12/2000 | EP0970186A1 SpoOJ2 OF STAPHYLOCOCCUS AUREUS |
| 01/12/2000 | EP0970128A1 Immunotherapeutic ctla-4 binding peptides |
| 01/12/2000 | EP0970127A1 Antibody variants |
| 01/12/2000 | EP0970126A2 Method for the production of antihuman antigen receptors and uses thereof |
| 01/12/2000 | EP0970125A2 Histidine decarboxylase immunoreactivity to detect cancer |
| 01/12/2000 | EP0970115A1 Viral peptides with structural homology to protein g of respiratory syncytial virus |
| 01/12/2000 | EP0970114A1 Neoglycoproteins |
| 01/12/2000 | EP0970107A1 Cyclosporine derivatives and uses thereof |
| 01/12/2000 | EP0969877A1 Methods for the modulation of the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 01/12/2000 | EP0969873A1 Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof |
| 01/12/2000 | EP0969872A2 Induction of b cell tolerance |
| 01/12/2000 | EP0969867A2 Use of anti-il-12 antibodies in transplantation rejection |
| 01/12/2000 | EP0969866A1 Immunotherapy of b-cell malignancies using anti-cd22 antibodies |
| 01/12/2000 | EP0969864A1 Hiv p-17 peptide fragment, compositions containing and methods for producing and using same |
| 01/12/2000 | EP0969863A1 Viral defective interfering particles and uses thereof |
| 01/12/2000 | EP0969862A2 SYNTHETIC HIV $i(GAG) GENES |
| 01/12/2000 | EP0969855A1 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 01/12/2000 | EP0969851A1 Immunomodulatory complex and use thereof in helicobacter diseases |
| 01/12/2000 | EP0722341B1 Non-ionic surfarctant vesicles comprising antigens |
| 01/12/2000 | EP0658120B1 Conjugates of poorly immunogenic antigens and synthetic peptide carriers and vaccines comprising them |
| 01/12/2000 | EP0639079B1 Methods for treating interleukin-1 and tumor necrosis factor mediated diseases |
| 01/12/2000 | EP0594764B1 Hematopoietic growth factor derived from t lymphocytes and methods of use therefor |
| 01/12/2000 | EP0548234B1 Cloning of chicken anaemia dna |
| 01/12/2000 | CN1241258A VEGF-8/receptor complex and uses thereof |
| 01/12/2000 | CN1241212A Compound and methods for immunotherapy and diagnosis of tuberculosis |
| 01/12/2000 | CN1241193A Meningococcus vaccine comprising valence of BZ23 strain |
| 01/12/2000 | CN1240664A Medicine for treating pancreatitis by immunotherapy and its preparing method |
| 01/11/2000 | US6013781 Semaphorin gene family |
| 01/11/2000 | US6013770 Chimeric contraceptive vaccines |
| 01/11/2000 | US6013765 Cell surface peptides that can be used as antitumor agents |
| 01/11/2000 | US6013519 Monoclonal antibodies to antigens expressed by hematopoietic facilitatory cells |
| 01/11/2000 | US6013514 Nucleic acid sequence coding for a membrane protein; for treatment diagnosis, dectection, and prevention of infections |
| 01/11/2000 | US6013505 Polynucleotide sequence coding a polypeptide in vovolved in coiling deoxyribonucleic acids; for diagnosis and antibiotic development against bacterial infection |
| 01/11/2000 | US6013497 Polynucleotide sequence that codes a polypeptide; bactericides |
| 01/11/2000 | US6013484 HIV-3 retrovirus and its use |
| 01/11/2000 | US6013482 Polynucleotide sequence coding a ahdesion protein that is on the surface of a cell; for screening drugs that modulate cell surface protein activity; diagnosis of bacterial infection; bactericides |
| 01/11/2000 | US6013480 Antagonists of interleukin-15 |
| 01/11/2000 | US6013463 Diagnostic test kit for detecting campylobacter infection; for diagnosis of peptic ulcer disease or gastrointestinal cancer |
| 01/11/2000 | US6013454 Kinesin-like motor protein |
| 01/11/2000 | US6013450 CAF1-related protein |
| 01/11/2000 | US6013268 Methods for enhancement of protective immune responses |
| 01/11/2000 | US6013267 Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis |
| 01/11/2000 | US6013266 Live attenuated bacteria of the species Actinobacillus pleuropneumoniae |
| 01/11/2000 | US6013265 For immunization against and preventing clinical symptoms associated with herpes simplex virus infections |
| 01/11/2000 | US6013264 Comprising hepatitis b surface antigen (hbsag); stability, efficiency; for immunization against diphtheria, tetanus, pertussis, polio, haemophilus influenzae b, hepatitis a, meningitis a, meningitis b, meningitis c, and otitis media |
| 01/11/2000 | US6013263 As inhibitory of human and non-human retroviral, especially human immunodeficiency viurs (hiv), transmission to uninfected cells |
| 01/11/2000 | US6013262 Recombinant papilloma virus L1 |
| 01/11/2000 | US6013261 For immunization |
| 01/11/2000 | US6013258 Immunogenic peptides from the HPV E7 protein |
| 01/11/2000 | US6013257 Neurotactin and uses therefor |
| 01/11/2000 | US6013256 Administering to human patients undergoing renal transplants effective dosage of chimeric or humanized monoclonal antibody that binds to p55 subunit of human interleukin-2 (il-2) receptor and inhibits binding of il-2 to an il-2 receptor |
| 01/11/2000 | US6013240 Nucleic acid containing composition, preparation and uses of same |
| 01/10/2000 | CA2274984A1 Candida albicans gene (csa1) encoding a mycelial surface antigen, and uses thereof |
| 01/10/2000 | CA2237134A1 Csa1 gene coding for a candida albicans surface antigen, diagnostic and therapeutic uses thereof |
| 01/06/2000 | WO2000000825A2 Detection and modulation of cellular immunity to immune privileged antigens |
| 01/06/2000 | WO2000000634A2 METHODS OF INHIBITING $i(HELICOBACTER PYLORI) |
| 01/06/2000 | WO2000000628A1 Replication-defective recombinant adenovirus with mutated major late promoter |
| 01/06/2000 | WO2000000617A2 Ebola virion proteins expressed from venezuelan equine encephalitis (vee) virus replicons |
| 01/06/2000 | WO2000000616A2 Marburg virus vaccines |
| 01/06/2000 | WO2000000614A2 NOVEL ANTIGENS OF $i(HELICOBACTER PYLORI) |
| 01/06/2000 | WO2000000610A2 Human signal peptide-containing proteins |
| 01/06/2000 | WO2000000608A2 Immune system molecules |
| 01/06/2000 | WO2000000603A2 Modularly constructed rna molecules having two sequence region types |
| 01/06/2000 | WO2000000596A1 3'-exonuclease, production and use thereof |
| 01/06/2000 | WO2000000594A2 Human transferases |
| 01/06/2000 | WO2000000592A1 Monoclonal antibody 3-6-a specific to surface of dendritic cells among the peripheral blood leukocytes |
| 01/06/2000 | WO2000000587A1 Methods of expanding and selecting disease associated t-cells |
| 01/06/2000 | WO2000000223A2 ANTIVIRAL AND ANTIRETROVIRAL RADIOIMMUNOMEDICAMENTS BASED ON α-EMITTERS AND β-EMITTERS |
| 01/06/2000 | WO2000000218A1 Mucosal targeting immunisation |
| 01/06/2000 | WO2000000217A1 Mucosal targeting immunisation |
| 01/06/2000 | WO2000000216A2 Use of poxviruses as enhancer of specific immunity |
| 01/06/2000 | WO2000000215A1 Particulate delivery systems and methods of use |
| 01/06/2000 | WO1999057270A3 Human receptor molecules |
| 01/06/2000 | WO1999056776A3 Adjuvant composition and methods for its use |
| 01/06/2000 | WO1999055874A3 Nucleic acids of the m antigen gene of histoplasma capsulatum, antigens, vaccines and antibodies, methods and kits for detecting histoplasmosis |
| 01/06/2000 | WO1999055364A3 Proteins that direct the secretion of virulence proteins and vaccines comprising them |
| 01/06/2000 | WO1999043829A3 Cell cycle related proteins |
| 01/06/2000 | WO1999029310A3 Regulation of t cell-mediated immunity by tryptophan and its analogs |